13104_2015_1292_MOESM1_ESM.ppt (141 kB)
Additional file 1: of Assessment of adverse events via a telephone consultation service for cancer patients receiving ambulatory chemotherapy
presentation
posted on 2015-07-26, 05:00 authored by Shunsuke Kondo, Satoshi Shiba, Ryoko Udagawa, Yasuaki Ryushima, Miho Yano, Tomoko Uehara, Mihoko Asanabe, Kenji Tamura, Jun HashimotoFigure S1. A) Common adverse events reported during consultation. B) Chemotherapy regimens of patients using the telephone consultation service. AC; adriamycin + cyclophosphamide, CBDCA; carboplatin, PTX; paclitaxel, GEM; gemcitabine, CEF; cyclophosphamide + epirubicine + 5-FU, CDDP; cisplatin, BV; bevacizumab.